Patents by Inventor Lars Linder

Lars Linder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075106
    Abstract: The present invention is directed to use of the GLP-1 receptor agonist semaglutide in medical therapy for the treatment of non-alcoholic steatohepatitis.
    Type: Application
    Filed: October 24, 2023
    Publication date: March 7, 2024
    Inventors: Morten Hansen, Martin Linder, Carl Richard Torstenson, Mads Sundby Palle, Lars Holm Damgaard
  • Patent number: 5665121
    Abstract: A prosthesis having attachment portion for insertion into or attachment to a patient's bone without bone cement. Parts of the attachment portion on the prosthesis are attached to the bone are covered with a mantle of synthetic resin material and which has a roughened outer surface with bone fragments or calcium phosphate fragments embedded therein.
    Type: Grant
    Filed: February 29, 1996
    Date of Patent: September 9, 1997
    Assignee: Howmedica International
    Inventors: Graham A. Gie, Peter Lawes, Lars Linder, Robin S. M. Ling, Tom J. Slooff
  • Patent number: 5188617
    Abstract: An apparatus for taking samples from gum pockets, including a holder (1) for an ampoule (3) detachably inserted therein, a manually operated element (2) cooperating with the holder for reducing the space in the ampoule, so that liquid contained therein will be fed out through a cannula (4) connected to the holder, the cannula being intended to be inserted in a gum pocket. The apparatus is provided with means for restoring at least partly the space in the ampoule for feeding a mixture of sample and liquid into the ampoule.
    Type: Grant
    Filed: October 16, 1990
    Date of Patent: February 23, 1993
    Assignee: Triple L. Laboratories AB
    Inventor: Lars Linder